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Abstract
Retroviruses have been infecting mammals for at least 100 million years, leaving descendants in host genomes known as
endogenous retroviruses (ERVs). The abundance of ERVs is partly determined by their mode of replication, but it has also
been suggested that host life history traits could enhance or suppress their activity. We show that larger bodied species
have lower levels of ERV activity by reconstructing the rate of ERV integration across 38 mammalian species. Body size
explains 37% of the variance in ERV integration rate over the last 10 million years, controlling for the effect of confounding
due to other life history traits. Furthermore, 68% of the variance in the mean age of ERVs per genome can also be explained
by body size. These results indicate that body size limits the number of recently replicating ERVs due to their detrimental
effects on their host. To comprehend the possible mechanistic links between body size and ERV integration we built a
mathematical model, which shows that ERV abundance is favored by lower body size and higher horizontal transmission
rates. We argue that because retroviral integration is tumorigenic, the negative correlation between body size and ERV
numbers results from the necessity to reduce the risk of cancer, under the assumption that this risk scales positively with
body size. Our model also fits the empirical observation that the lifetime risk of cancer is relatively invariant among
mammals regardless of their body size, known as Peto’s paradox, and indicates that larger bodied mammals may have
evolved mechanisms to limit ERV activity.
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Introduction
Mammalian genomes contain large numbers of endogenous ret-
roviruses (ERVs), derived from multiple independent germline
invasions over evolutionary time. The human genome contains
31–40 such ERV invasions, termed ‘families’, each derived from a
distinct ancestral exogenous retrovirus [1,2]. These ERVs can con-
tinue proliferating after the initial germline invasion until they are
inactivated, either through the acquisition of substitutions that
occur at the host background level (,1023 per base per my) or by
recombinational deletion [3,4]. Most ERV families proliferate by
reinfection, although some ERVs occasionally switch from rein-
fecting germline cells to an entirely intracellular life, and this switch
can lead to an increase in the size of the ERV family [5]. As a result
of these processes, ERVs have come to occupy ,5–10% of their
hosts’ genomes [6,7].
The fixation of a new ERV insertion is influenced by its fitness
consequences to the host, and other population genetic parameters
[8]; for example a neutral ERV could fix by drift, and a slightly
deleterious insertion may hitchhike or fix during a population
bottleneck [9]. A small number of ERVs have been exapted and
have beneficial functions in their host [10–12], but the integration
of retroviruses into or near host genes can have highly deleterious
effects, as the consequent disruption or alteration of gene expression
can lead to malignant transformation [13]. Furthermore, illegiti-
mate recombination between ERVs at different loci can also have
deleterious effects, as can the expression of viral proteins. The
uncontrolled proliferation of ERVs would therefore be extremely
detrimental to their host [14], and this process must be limited either
by cessation of replication activity, or by host mediated suppression
[15].Vertebrate genomes have evolved a range of responses that act
at various stages of the viral life cycle to limit retroviral replication
and its associated tumorigenic potential [16,17].
The diversity and activity of ERVs across mammalian genomes
has not been systematically assessed, and it remains unclear what
factors have determined ERV abundance in their hosts. Mice and
humans, the first two mammalian species to have their genomes
sequenced, show strikingly different patterns of ERV activity – most
human endogenous retroviruses are inactive, with a striking decel-
eration in activity over the last 25 million years [7]. In contrast, the
mouse genome shows no sign of deceleration in ERV activity and a
large number of murine ERVs are active and unfixed in the mouse
population [6]. This difference is also reflected in the proportion of
catalogued mutant alleles that are due to ERV insertions;,10% of
mutant alleles can be attributed to ERVs in mice, whereas no such
alleles can be attributed to ERVs in humans [18]. It has been sug-
gested that themarkedly different ERV activity in human andmouse
genomes can be explained by systematic factors in the biology of
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these hosts [14]. We explore the hypothesis that differences in ERV
activity across mammals are determined by differences in host life
history, with smaller bodied animals expected to have higher levels
of ERV activity. We compare body size with ERV numbers using
data from a diverse set of 38 mammals in a multivariate analysis,
controlling for confounding variables such as life history traits. We
also explore the effect of body size and horizontal transmission on
ERV dynamics through a mathematical model. Finally, we discuss
our associations of body size and ERV replication in the light of
evolutionary theory and cancer biology.
Results
Body size has a negative correlation with ERV abundance
across mammals
By analysing 38 mammalian genomes over approximately the
last 10 my period we find a negative relationship between the
number of integrated ERVs and body size (Figure 1b, Figure 2a).
The correlation is robust if instead of present day body size we use
the reconstructed body size at 5 million years ago (P = 0.0069,
R2= 0.31), and remains significant if we use a single substitution
rate for all mammals (P=0.01, R2= 0.25). The correlation is depen-
dent on the age of the integration in the genome and is no longer
significant when we consider ERVs that are older than 10 my
(Figure 1c, Figure 1d). If we exclude ERVs that belong to our previ-
ously defined megafamilies [5] with mean divergence,10%, namely
the IAP family from Cavia Porcelus, the IAP family fromDipodomys
Ordii, a Class I family from Felis catus, and the IAP and ERV-L
families from Mus Musculus, the correlation remains (P= 0.0042,
R2= 0.30). If we split ERVs into their traditional classes, the
correlation is significant only for the class II ERVs (Figure 3). There
is no data to suggest systematic differences in the biology of
retroviruses from different classes, given that the majority of ERVs
are derived from extinct retroviral lineages. The three classes differ
in their age distribution; class II ERVs are much younger (Figure 4),
with the majority of insertions falling within the 10 my era that we
use to define the young age category. Thus the observed relationship
between body size and Class II ERVs is likely due to their recent
replication and not some other difference in their biology such as
higher pathogenicity.
The correlation of body size with ERV abundance is not
confounded by another life history trait
Since life history traits are correlated with each other, it is pos-
sible that the apparent and inferred correlation of ERVs with body
size could be confounded by another trait such as reproductive
output (for which gestation period is a proxy) and timing (age at
sexual maturity) [19]. The number of mates or the type of placenta
might also influence ERV abundance via an increased risk of hor-
izontal or vertical retroviral transmission, respectively. To clarify if
number of sexual partners has played a role in determining the
number of ERVs per genome, we use testis size as a proxy as it is
known to correlate with the number of mates and the strength of
sexual selection in mammals [20,21]. To assess the effect of the
placental type we modeled placental invasiveness as a semiquan-
titative parameter (i.e. marsupials = 1, epitheliochorial = 2, endo-
theliochorial = 3 and hemochorial = 4) [22]. We evaluated the
correlation between ERV integration rate and potential con-
founders with multivariate models and standard stepwise forward
model selection. We included in turn the following confounding
variables; time to sexual maturity, gestation period, life span, testis
size and placental invasiveness. Body size remained as the only
significant variable confirming that it is the only significant predictor
of ERV integration rate over the last 10 my (Table 1). The models
remain significant when we account for phylogenetic non-indepen-
dence [23], reconstruct ancestral mass and/or incorporate a body
mass dependent substitution rate. Thus, unlike substitution rate
[24,25], ERV integration rate is not a result of shorter generation
time. We do not find a significant correlation with testis size, either
as an additional predictor variable (P= 0.3) with body size included
in the model, or as an interaction term with body size (P= 0.2).
Thus, the number of mates does not appear to have played a
significant role on the number of ERVs per genome.
Another possible confounder is the effective population size of
the host [26]: species with higher effective population sizes are
expected to be more efficient at purging slightly deleterious muta-
tions such as those incurred by ERV proliferation [27]. As a result,
since larger bodied animals have smaller effective population sizes
[19,28], we would expect them to have more, not fewer ERVs.
Thus, confounding due to effective population size would lead to a
correlation in the opposite direction to what we observe, indicating
that the observed correlation between body size and ERV
numbers is robust against variations in effective population size.
Relationship between ERV abundance and body size can
be explained by a mathematical model of retrovirus-host
dynamics
To explore the possible mechanistic links between body size,
integration rate and transmission route, we designed a mathemat-
ical model (Figure S1). We constructed a compartmental mathe-
matical model using a system of ordinary differential equations to
describe the epidemiological dynamics of exogenous and endog-
enous retroviral infections. There are two broad classes of indivi-
duals that need to be considered, the susceptible population Sð Þ
and the infected population. In order to gain a more detailed
picture of the latter compartment, namely to elucidate the inter-
connected roles between exogenous and endogenous retroviral
infections, we further distinguish three infected sub-populations:
individuals infected with an exogenous retrovirus IRVð Þ, those
infected with a single integrated copy of the retrovirus through the
Author Summary
Retroviruses have been invading mammalian genomes for
over 100 million years, leaving traces known as endoge-
nous retroviruses (ERVs). Early genome sequencing studies
revealed a marked difference in the activity of retroviruses
among species, with humans largely containing inactive
lineages of ERVs, while the mouse contains numerous
lineages of active ERVs. We explore the hypothesis that life
history traits determine the activity of ERVs in mammalian
genomes, and show that larger mammals have fewer ERV
copies over recent evolutionary time (the last 10 million
years) compared to smaller mammals. This association is
determined by body size independently of any confound-
ing variables. We build a mathematical model that shows
that ERV abundance in genomes decreases with larger
body size and increases with horizontal transmission.
Retroviral integration can cause cancer, and our analysis
suggests that larger bodied animals control ERV replication
in order to postpone cancer until a post-reproductive age.
This is in line with a long-standing observation that cancer
rates do not fluctuate among mammals of different body
size, a phenomenon known as Peto’s paradox, and opens
up the possibility that larger animals have evolved
mechanisms to limit ERV activity.
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process of endogenisation IERVð Þ, and lastly, those infected with
an endogenous retrovirus that has undergone amplification IAERV
 
.
The overall level of retroviral activity is directly related to the
copy number of endogenised retroviruses in the infected popula-
tion. Since the vast majority of endogenous retrovirus present in
the host population persists in the pool of AERV-infected indivi-
duals, the level of retroviral activity can be represented by the
magnitude or size of this compartment. We first explore the roles
of three key factors: body size Bð Þ, the rate of retroviral endog-
enisation sð Þ which governs vertical transmission of the retrovirus,
and the force of infection lð Þ which determines the rate of hori-
zontal transmission of the retrovirus. As shown in Figure S2
increased body size results in a lower number of individuals har-
bouring amplified endogenous retrovirus when this system reaches
equilibrium, (Figure S2, upper plot), while the rate of retroviral
endogenisation sð Þ and the force of infection lð Þ display the
opposite relationship (Figure S2, lower plot).
Our model demonstrates that horizontal and vertical transmis-
sion are both crucial for the eventual endogenisation and ampli-
fication of the retrovirus. If there is no horizontal transmission (i.e.
Figure 1. (a) Correlation between mean age of all ERV integrations and body mass from the genomes of 38 mammals. Body mass is
log-transformed, and the mean ages are calculated correcting for the substitution rate (R2 = 0.68, P,0.001). (b, c, d) The relationship between ERV
count and body mass for the number of ERV integrations acquired over the last 10 my, between 10–35 mya and .35 mya in the genomes of 38
mammals (both values log-transformed). The trend lines representing the slope for the regression, corrected for phylogenetic non-independence,
and accompanying P-values are plotted. We have taken into account the effect of body size on substitution rate in calculating the ages.
doi:10.1371/journal.ppat.1004214.g001
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l:0), then the retrovirus cannot spread and persist in the popu-
lation, even if there is a large initial pool of infected individuals
(figure 5). Similarly, in the situation where no endogenisation events
occur via vertical transmission (i.e. s~0), our model shows that
infection can become endemic, but remains completely exogenous.
We explored the impact of body size on the structure of the
population at equilibrium in relation to the extent of retroviral
endogenisation s and the force of infection l (Figure 5) in more
detail. The results in Figure 5 illustrate that higher rates of hori-
zontal transmission, represented by the force of infection lð Þ, lead
to a higher proportion of AERV infections for a given body size,
and furthermore, highlight our finding that larger body size Bð Þ is
associated with a lower extent of AERV activity, with all other para-
meters fixed (Figure S2, lower plot). Furthermore, we observe from
Figure 5 that for sufficiently high rates of horizontal transmission,
the proportion of AERV infections plateaus with respect to increas-
ing body size Bð Þ. In this case, larger body size is associated with a
greater proportion of exogenous infections, as new (exogenous) infec-
tions would arise through horizontal transmissions at a faster rate
than endogenisation via vertical transmissions. To explore the possi-
bility that the number of horizontal transmissions confound the
number of elements per genome, we tested if the number of families
per genome is correlated with body size, and find no significant
correlation (P= 0.15, R2= 0.08).
Figure 2. (a) Correlation between ERV count and body mass for the number of ERV integrations acquired over the last 10 my. (b)
Correlation between mean age of all ERV integrations and body mass from the genomes of 38 mammals. Body mass is log-transformed, and the
mean ages are calculated correcting for the substitution rate. We have not taken into account the effect of body size on substitution rate in
calculating the ages.
doi:10.1371/journal.ppat.1004214.g002
Figure 3. Correlations of number of ERVs against body mass (both log-transformed) by ERV class.
doi:10.1371/journal.ppat.1004214.g003
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Discussion
We identified 84,223 ERVs, of which 27,711 have integrated in
the last 10 my across 38 species of mammal (Table 2). We find that
the number of ERV integrations inmammals is negatively correlated
to body size. This correlation can explain 37% of the variance in
the number of ERV integrations over the past 10 my. We have
controlled for confounding variables such as life history and sexual
selection, and also confirmed robustness to variation in effective
population size. Nevertheless body size can be influenced by other
parameters, and it is possible that other factors (e.g. environmental,
dietary) contribute to both body size and ERV abundance, thereby
explaining part of the remaining variance; for example they might
account for the residual variance of outliers (e.g. Dasypus
Novemcinctus and Canis familiaris). Interestingly, Microcebus
murinus, whose life his-
tory evolved rapidly due to its isolation in Madagascar [29], might
be expected to be a significant outlier in the correlation, but is
very close to the regression line. Perhaps the global distribution and
geographic isolation of a species is another determinant of the
variance in ERV abundance.
We also see that 68% of the variance observed in the mean age
of ERV integrations in a genome (a proxy for recent replication) is
explained by body size (Figure 1a), with the number of young (i.e.
recently replicating) insertions correlating inversely with body size
(Figure 1b) while the number of older insertions do not (Figure 1c,
Figure 4. Age distribution of ERVs by class.
doi:10.1371/journal.ppat.1004214.g004
Table 1. Phylogenetically corrected correlations of number of ERVs per genome acquired over the last 10 my (log) against life
history traits (LHT) confounders.
Univariate analyses Mutlivariate analyses
Life traits (LT) Coefficient P
LHT confounder
coefficient P
Body Mass (log)
coefficient P
Number of
species
Time to sexual maturity (ln) 20.27 0.15 0.06 0.8 20.39 0.03 38
Gestation period (ln) 20.0011 0.45 0.22 0.5 20.3 0.02 38
Life span (ln) 20.36 0.13 20.36 0.12 20.25 0.04 38
Testis mass (ln) 20.24 0.01 20.06 0.78 20.15 0.2 24
Placental invasiveness 0.34 0.008 0.18 0.12 20.15 0.02 37
doi:10.1371/journal.ppat.1004214.t001
Mammalian Body Size and Retroviral Activity
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d). These observations suggest that body size limits the number of
ERVs in a genome and that the presence of recently replicating
ERVs is detrimental to their host. As ERVs accumulate host-
induced mutations over time, their activity diminishes until they
eventually become neutral. Our study suggests that ERVs that
have been active within the last 10 million years could still have
moderately deleterious effects, probably in the post reproductive
age. Furthermore, the age of an ERV is a good proxy for its path-
ogenic potential, with pathogenicity decreasing over time. Some
ERV families have retained replication capacity for millions of years;
HERV-K (HML2) first invaded the primate genome .30 my yet
has still been active up until at least ,500,000 years ago [30,31].
These recently active ERVs may retain some level of virulence, and
therefore still have the potential for malignant transformation [13].
In line with this prediction of intermediate virulence, reconstructed
ERVs [32] or recently established present day ERVs [33,34] have
low but detectable viral loads. The presence of pathogenic ERVs in
a genome after such a long period of time may appear surprising. It
could however be explained by analogy to models of the transmis-
sibility of pathogens within the context of host-parasite co-evolu-
tionary dynamics [35,36]. Such models incorporate the effects of
both transmissibility and virulence on the reproductive success of a
parasite, and show that they do not necessarily evolve to be harm-
less; in some empirical datasets reproductive success is maximised
Figure 5. The effect of body size (B) for different horizontal transmission rates (l ) on the structure of the population at equilibrium.
At high rates of horizontal transmission (l), the proportion of infected individuals reaches a plateau for increasing body sizes. Moreover, in this case,
for larger body sizes, there is a greater proportion of exogenous retrovirus infections than there are endogenous ones.
doi:10.1371/journal.ppat.1004214.g005
Mammalian Body Size and Retroviral Activity
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at intermediate levels of both of these parameters [35]. In other
words a pathogen can continue to be virulent despite selection
imposed by the host for a more benign infection.
We have modelled the spread of retroviruses among hosts and
within genomes, distinguishing between exogenous and endoge-
nous retroviruses, and taking into account vertical and horizontal
modes of transmission. A key aspect of our model is the assump-
tion that the deleterious effects of a retrovirus in a genome scale
with body size. The model shows that as body size increases, the
proportion of individuals in the host population that carry ERVs
drops (figure S2). Elevated rates of either endogenisation or hori-
zontal transmission lead to higher ERV abundance and accelerate
the rate at which ERV abundance increases with body size. For
any given rate of horizontal transmission however the overall rela-
tionship between body size and ERV abundance is maintained
(figure 5). In our model, the body size-associated pathogenic effect
of an ERV in a genome is equivalent, whether it has been generated
by vertical or horizontal transmission. Horizontal transmission of an
ERV would require somatic expression and replication of the virus
in order to propagate effectively, which may in turn increase the
mortality of the host via a direct result of retroviral infection. Experi-
mental evidence suggests that infections with replication competent
retroviruses are more pathogenic when retroviral replication is high
(e.g. HIV, or the recently endogenised Koala retrovirus [34,37]).
One way in which the pathogenicity of an ERV can be reduced
while its replicative capacity is maintained is through epigenetic
regulation in somatic cells. During genomic reprogramming of the
germline, transposable elements are expressed and can replicate
before being silenced [38,39], resulting in lower levels of expression
in somatic tissues and hence lower transmissibility. Thus, low levels
of replication in somatic cells may be favorable for an ERV, enabling
it to maximize its own success via vertical transmission while min-
imizing harm to the host. The association between ERV abun-
dance and body size indicates that somatic replication cannot be
completely suppressed and that the pathogenetic effects of ERVs
cannot be dissociated from their copy number.
On a macroevolutionary timescale, ERV copy number will be
determined both by the number of cross species transmissions and
the subsequent proliferation of ERV families. The number of families
per genome is orders of magnitude lower than the number of ERVs
(mean number of families = 23, mean number of elements= 1073),
and most ERVs within a genome come from a small number of
families, the so-called superspreaders (or megafamilies) [5]. In line
with this uneven distribution of ERVs among families, we do not see
a correlation between the number of families within a genome and
body size (P=NS, R2= 0.08). Furthermore, ERVs that belong to
megafamilies lack the env genome that is required for horizontal
transmission, highlighting the importance of vertical transmission in
determining ERV abundance, despite the ability of ERVs to cross
species on timescales spanning millions of years.
Crucially, according to our model the selective cost of an ERV
is determined by the body size of the host. Larger bodied animals
would be expected to have a higher lifetime risk of cancer as a con-
sequence of having both more dividing cells and longer lifespans.
No such association is observed in nature, with relatively invariable
risks of cancer in animals with differing body sizes, a phenomenon
known as Peto’s Paradox [40,41]. Under our model, the risk of
retrovirally induced cancer also scales similarly with body size. The
observed negative correlation between body size and ERV integra-
tion rate suggests that larger mammals attain a lower ERV virulence
cost per body size unit by reducing the number of ERVs in their
genome. This should therefore enable them to postpone the onset of
cancer until after their reproductive age.T
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Our results indicate that larger animals exert greater control
over ERV proliferation. This could be due to the evolution of
mechanisms capable of limiting retroviral activity and consequently
limiting the incorporation of ERVs in the genome. Such mecha-
nisms could involve the enhancement of innate or adaptive responses
to retroviruses [16,17], or perhaps epigenetic regulation [42] is more
potent in larger mammals. An intriguing alternative is that the effect
is indirect via an improved immune surveillance – some genes
involved in pattern recognition for defence against pathogens such
as viruses are also involved in controlling cancers [43]. Antiviral
genes are the result of a continuous and ancient arms race between
viruses and their hosts [15], and elucidating their roles in controlling
cancer across animals of different body size could provide insights
into cancer susceptibility.
Materials and Methods
ERV mining and dating of insertions
Our mining of the 38 mammal genomes has been described
previously [5,44,45]. We estimated age based on the divergence from
the most similar other ERV insertion in the same genome (‘‘nearest
neighbour’’). We favour this approach over cruder metrics that are
based on divergence from a consensus sequence, as it takes into
account the phylogeny of the ERVs, and over approaches based on
divergence between paired LTRs due to the variable quality of the
genomes being analysed, most of which do not contain contigs that
are long enough to include complete proviral elements. We first
calculated nucleotide divergence from the most similar other ERV
insertion in the same genome as described in Magiorkinis et al. [5],
and then converted this to an integration date assuming a mean
nucleotide substitution rate at neutral nuclear protein coding sites
in mammals of 2.261029 per site per year [46], and corrected for
multiple hits using the Jukes-Cantor model. To calculate the aver-
age age of ERVs in each genome we took into account the known
effect of body size on substitution rate by using a regression of rate
against mass with slope of 20.09, i.e. log(adjusted rate) = 0.096
(log(mean mass)2log(mass))+log(unadjusted rate) [47]. We also
repeat the correlation between body size and ERV number with a
single substitution rate for all mammals.
Incorporating ancestral body mass
Using the data above we reconstructed ancestral body masses
assuming a Brownian motion model of trait evolution as imple-
mented in the package GEIGER in the R language [48]. This
program returns the estimated body mass at nodes in the tree, and
from these we calculated values at the mid-points of our time
intervals (averaging where necessary). We then manually pruned
our trees to this point and repeated the regression between number
of ERVs and body mass for each time interval, taking the phy-
logeny into account (Table 2). Our regressions were performed
with both present day body size and the reconstructed body size at
the mid-point of our time intervals (e.g. body size at 5 million years
ago for regression against activity during the last 10 million years).
Multivariate analysis
Life history traits correlate with each other; for example larger
bodied animals tend to live longer and have smaller effective
population size [19,28]. Therefore body size could in principle be
a surrogate measure of a different life history trait, as has been pre-
viously shown for substitution rate [24]. Mammalian life history
data was taken from [49] and the phylogenetic tree from [50]. We
collected the testis size for 24 out of 38 species in our study (Table
S1). We used the Generalized Least Squares (GLS) approach as
implemented by the Analysis of Phylogenetics and Evolution
(APE) package [51] in R. We used standard model selection to
identify significant confounders of ERV numbers per genome
(Table 1).
A mathematical model of ERV persistence and evolution
Model (1) captures the fundamental dynamics of retroviral
infections including the processes of retroviral endogenisation and
amplification. The key interactions of the model are illustrated
schematically in Figure S1.
dS
dt
~ b
z}|{new susceptible births
{ lS
z}|{transmission from RVzAERV infected
{ mS
z}|{death of susceptibles
dIRV
dt
~ lS
z}|{new infections from from RVzAERV
{ mIRV
zﬄ}|ﬄ{death of RV infected
dIERV
dt
~ smIRV
zﬄﬄ}|ﬄﬄ{births with integrated ERV
{ a(B)IERV
zﬄﬄﬄﬄﬄ}|ﬄﬄﬄﬄﬄ{amplification
{ mIERV
zﬄﬄ}|ﬄﬄ{death of ERV infected
dIAERV
dt
~ mIAERV
zﬄﬄﬄ}|ﬄﬄﬄ{births of AERV by AERV infected
{ a(B)IERV
zﬄﬄﬄﬄﬄ}|ﬄﬄﬄﬄﬄ{amplification
{ (mzmAERV (B))IAERV
zﬄﬄﬄﬄﬄﬄﬄﬄﬄﬄﬄﬄﬄﬄﬄﬄﬄ}|ﬄﬄﬄﬄﬄﬄﬄﬄﬄﬄﬄﬄﬄﬄﬄﬄﬄ{death of AERV
infected, background and cancerinduced
ð1Þ
where b~m N{sIRV{IAERV
 
zmAERV (B)IAERV and l~
b1I
RV=Nzb2I
AERV=N.
In model (1), we consider both vertical and horizontal routes of
transmission. We also distinguish between exogenous and endog-
enous retroviral infections. Whereas horizontal transmission can
only lead to infection with an exogenous retrovirus (i.e. RV com-
partment), vertical transmission can result in retroviral endogen-
isation (i.e. ERV compartment) and subsequent amplification (i.e.
AERV compartment).
There are two ways in which new (exogenous) retroviral infec-
tions may arise horizontally in an initially susceptible individual,
either through contact with an individual infected with an exog-
enous retrovirus (i.e. RV compartment), or alternatively via
exposure to an individual infected with an amplified endogenous
retrovirus (i.e. AERV compartment). We assume that individuals
infected with only a single integrated copy of the retrovirus (i.e.ERV
compartment) are unable to transmit the infection horizontally
between hosts. The force of infection l is composed of two terms,
l~l1zl2, and thus reflects the dual modes of horizontal
transmission. There are various different functional forms for the
force of infection, and we choose the commonly used form
l~b1I
RV=Nzb2I
AERV=N, where b1 and b2 are the respective
coefficients of infectious trans-
missibility for RV-infected and AERV-infected individuals, andN is
the total population which is assumed to be constant.
A small proportion s, where 0ƒsƒ1, of births from individuals
who are infected by an exogenous retrovirus acquire an integrated
endogenous copy of the retrovirus, thereby entering the ERV com-
partment. Meanwhile, individuals infected with an integrated endog-
enous retrovirus (in the ERV compartment) undergo retroviral
Mammalian Body Size and Retroviral Activity
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amplification at a rate a(B), which is dependent on body size (B). A
consequence of retroviral amplification is a greater number of
endogenous retroviruses, therefore the size of the compartment of
individuals harbouring amplified, endogenised retroviruses is an
indirect measure of the overall extent of retroviral activity. Births
arising from infected individuals with amplified, endogenous retrovirus
(i.e. AERV compartment) themselves harbour amplified, endoge-
nous retroviruses.
To investigate the system without unnecessarily over-complicat-
ing the dynamical behaviour of the model, we consider a population
that is maintained at a fixed size (Nw0) so that (SzIRVzIERVz
IAERV )~N. The pool of susceptible individuals is maintained by
the birth of new susceptible individuals and is encapsulated in the
term b in the S equation, which includes new births of susceptibles
from all other compartments as well as a term to balance the in- and
out-flux of individuals in the system and ensure that the total
population remains constant. We assume that background birth and
death rates in each compartment are equal at a constant rate m.
Additional mortality due to the detrimental effects of amplified,
endogenous retroviral infection, such as the development of cancer,
is reflected in the parameter mAERV (B), which depends on body size
(B). Excess mortality as a consequence of cancer is fed back into the
susceptible pool so that, therefore the birth of susceptible individuals
can be encapsulated by the term b, where b~m N{sIRV{IAERV
 
zmAERV (B)IAERV
The above discussion highlights an important trade-off between
retroviral amplification a(B), which is beneficial to the long-term
persistence of the retrovirus, and increased mortality m(B) in excess
of background death rates as a consequence of the detrimental
effects associated with increased retroviral activity. These two fac-
tors both depend on body size (B), but in opposing ways. Whereas
larger body size means increased retroviral amplification, it also
results in greater mortality so that both a(B) and mAERV (B) are
increasing functions of B. We therefore investigate the role of body
size (B) on the outcome of infection. Several additional parameters
of significance are the force of infection l as well as the rate of ret-
roviral endogenisation s and how varying body size can influence
the dynamical behaviour of the infection according to model (1). For
the former, we explore how body size can affect the system when
differences between the force of infection (l) of individuals infected
with exogenous retrovirus (i.e. the IRV compartment) versus those car-
rying amplified, endogenous retrovirus (i.e. the IAERV compartment)
are taken into account. In terms of the latter, it is expected that a
higher rate of endogenisation would result in a greater proportion
of individuals with integrated endogenous retroviruses, and we are
interested in determining the role of body size with respect to
differences in endogenisation rates. Because we have assumed that
the total population remains constant, it is sensible to investigate the
dynamics of the model with respect to proportions of the total
population rather than in terms of the sizes of each compartment.
Supporting Information
Figure S1 A schematic diagram of the model representing the
interactions among four distinct subpopulations: susceptibles (S ),
infected with (exogenous) retrovirus (IRV), infected with integrated
(endogenous) retrovirus (IERV), and infected with amplified inte-
grated (endogenous) retrovirus (IAERV).
(EPS)
Figure S2 The results of model (1) show that the proportion of
the population infected with amplified, endogenous retrovirus (i.e.
the AERV -compartment) is associated with a larger body size (B),
and lower rates of endogenisation (s) and force of infection (l). The
model also predicts that a higher rate of retroviral endogenisation
(s) and a greater force of infection (l) are both linked to a shorter
time to reach the endemic steady state.
(EPS)
Table S1 Testis size for 24 species.
(DOCX)
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